Hugh Goodfellow > Carpmaels & Ransford LLP > London, England > Lawyer Profile
Carpmaels & Ransford LLP Offices
ONE SOUTHAMPTON ROW
LONDON
WC1B 5HA
England
- Firm Profile
- Go to...
Hugh Goodfellow
Work Department
Life sciences
Position
Hugh is the Managing Partner at Carpmaels & Ransford and a Partner in the Life Sciences team. He has a large prosecution practice, spanning Europe and beyond, and he is a regular visitor to the European Patent Office (EPO), handling many oppositions and appeals. He has pan-European expertise in the filing and prosecution of supplementary protection certificates nationally, as well as considerable experience before the European Court of Justice, including the widely cited Queensland (C-630/10), Neurim (C-130/11) and Abraxis (C-443/17) referrals.
Hugh has an “expansive practice” (IAM Patent 1000) with clients ranging from large and long-established global companies (e.g. Janssen, Takeda, Bristol Myers Squibb, Regeneron and Vertex) through to growing biotech companies (e.g., Akari, Radius Health, Hubrecht Organoid Technology, Translate Bio and Westway Health). During his career, he has been responsible for establishing the filing strategy and generating IP portfolios for a number of start-ups, guiding some of these clients all the way from early conception, through financing rounds and subsequent public flotation. His particular area of current focus includes biologics – in particular, therapeutic antibodies, complex immunology, biosimilar defence work and stem cell technology. Collectively, these experiences have developed Hugh’s ability to consistently and successfully protect foundation intellectual property and forecast potential future problems from the viewpoint of both IP generation and freedom to operate. Hugh has been noted as a “top-tier advisor” who “seamlessly links the firm’s prosecution division with its dispute resolution arm” (IAM Patent 1000).
Hugh received his BA (Hons) in Biochemistry and his MA and DPhil from the University of Oxford. His experience at the bench was spent investigating mechanisms of drug resistance in cancer cells. In addition to his work at Carpmaels & Ransford Hugh is a trustee for the UK charity Pancreatic Cancer Action.
Education
- BA (Hons) and MA Biochemistry (University of Oxford)
- DPhil (University of Oxford)
- Chartered Patent Attorney
- European Patent Attorney
- European Patent Litigator
Lawyer Rankings
London > Industry focus > Life sciences and healthcare
Praised for exhibiting ‘deep industry knowledge‘, Carpmaels & Ransford LLP is noted for assisting clients with trade marks, data protection, and orphan exclusivities. David Wilson has a great deal of experience in handling patent disputes concerning license agreements, and the ‘very talented and extremely dedicated‘ Jennifer Antcliff regularly appears before the Court of Appeal, Supreme Court, and the CJEU in SPC cases. Jake Marshall primarily focuses on transactional IP matters, and Hugh Goodfellow is particularly adept at the filing and prosecution of SPCs, and oppositions. James Warner leads on the chemical and pharmaceutical side, frequently handling EPO opposition proceedings. Mark Chapman heads up the biotech team, and has vast experience in pre and post-grant proceedings before the EPO.
London > TMT (technology, media and telecoms) > PATMA: Patent attorneys
(Leading Individuals)Carpmaels & Ransford LLP is notable for its expertise in supporting healthcare clients, including those from the pharmaceutical, chemical, and biotechnology industries. It is praised by clients for its ability to handle the entire spectrum of patent-related mandates, including ‘patent prosecution, strategy, post-grant proceedings, and litigation’, as well as EPO opposition work. The practice is also able to utilise the firm’s strong dispute resolution offering to assist in litigation matters. Managing partner and pan-European prosecution expert Hugh Goodfellow leads the life sciences group and is highly experienced in handling oppositions and appeals before the EPO, while John Brunner heads up the engineering and technology teams, assisting clients with their medical devises involving software, AI, and electronics. James Warner spearheads the chemistry and pharmaceuticals group, which advises clients in the consumer, nutraceuticals, and the medical device spaces, while Mark Chapman chairs the biotechnology team.
Lawyer Rankings
- Leading Individuals London > TMT (technology, media and telecoms) > PATMA: Patent attorneys
- PATMA: Patent attorneys London > TMT (technology, media and telecoms)
- Life sciences and healthcare London > Industry focus